Neeraj Sharma

Array ( [id] => 6821625 [patent_doc_number] => 20030219786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Novel glycoproteins and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/360149 [patent_app_country] => US [patent_app_date] => 2003-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 46170 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219786.pdf [firstpage_image] =>[orig_patent_app_number] => 10360149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7082648 [patent_doc_number] => 20050048028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Use of the insulin-like-growth factor i splice variant mgf for the prevention of myocardial damage' [patent_app_type] => utility [patent_app_number] => 10/504078 [patent_app_country] => US [patent_app_date] => 2003-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 13770 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048028.pdf [firstpage_image] =>[orig_patent_app_number] => 10504078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7193063 [patent_doc_number] => 20050163781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Tissue adhesion formation control' [patent_app_type] => utility [patent_app_number] => 10/502639 [patent_app_country] => US [patent_app_date] => 2003-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10990 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20050163781.pdf [firstpage_image] =>[orig_patent_app_number] => 10502639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705268 [patent_doc_number] => 20060194316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Bone marrow-derived neuronal cells' [patent_app_type] => utility [patent_app_number] => 10/353742 [patent_app_country] => US [patent_app_date] => 2003-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12681 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194316.pdf [firstpage_image] =>[orig_patent_app_number] => 10353742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6659187 [patent_doc_number] => 20030134334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Use of vascular endothelial growth factor (VEGF)' [patent_app_type] => new [patent_app_number] => 10/349111 [patent_app_country] => US [patent_app_date] => 2003-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6088 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134334.pdf [firstpage_image] =>[orig_patent_app_number] => 10349111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856161 [patent_doc_number] => 20030129662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Use of vascular endothelial growth factor (VEGF)' [patent_app_type] => new [patent_app_number] => 10/349074 [patent_app_country] => US [patent_app_date] => 2003-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6090 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20030129662.pdf [firstpage_image] =>[orig_patent_app_number] => 10349074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852000 [patent_doc_number] => 20030144203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Methods for slowing senescence and treating and preventing diseases associated with senescence' [patent_app_type] => new [patent_app_number] => 10/321579 [patent_app_country] => US [patent_app_date] => 2002-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16484 [patent_no_of_claims] => 186 [patent_no_of_ind_claims] => 48 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144203.pdf [firstpage_image] =>[orig_patent_app_number] => 10321579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7199954 [patent_doc_number] => 20050042199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Fusion proteins containing tlp peptides' [patent_app_type] => utility [patent_app_number] => 10/497178 [patent_app_country] => US [patent_app_date] => 2002-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2434 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042199.pdf [firstpage_image] =>[orig_patent_app_number] => 10497178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 928423 [patent_doc_number] => 07314733 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-01 [patent_title] => 'Saitohin gene and uses of same' [patent_app_type] => utility [patent_app_number] => 10/495545 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 14997 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/314/07314733.pdf [firstpage_image] =>[orig_patent_app_number] => 10495545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089631 [patent_doc_number] => 20050009744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Treatment of congestive heart failure' [patent_app_type] => utility [patent_app_number] => 10/494328 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2649 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009744.pdf [firstpage_image] =>[orig_patent_app_number] => 10494328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861118 [patent_doc_number] => 20030092126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Fragments of leptin (ob protein)' [patent_app_type] => new [patent_app_number] => 10/290144 [patent_app_country] => US [patent_app_date] => 2002-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5964 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092126.pdf [firstpage_image] =>[orig_patent_app_number] => 10290144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6787165 [patent_doc_number] => 20030138404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Interferon antagonists useful for the treatment of interferon related diseases' [patent_app_type] => new [patent_app_number] => 10/284740 [patent_app_country] => US [patent_app_date] => 2002-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 21236 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20030138404.pdf [firstpage_image] =>[orig_patent_app_number] => 10284740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7155764 [patent_doc_number] => 20050026822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Human 3 relaxin' [patent_app_type] => utility [patent_app_number] => 10/491919 [patent_app_country] => US [patent_app_date] => 2002-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15850 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026822.pdf [firstpage_image] =>[orig_patent_app_number] => 10491919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6668341 [patent_doc_number] => 20030113324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Neuropilin/VEGF-C/VEGFR-3 materials and methods' [patent_app_type] => new [patent_app_number] => 10/262538 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22593 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113324.pdf [firstpage_image] =>[orig_patent_app_number] => 10262538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730677 [patent_doc_number] => 20030186867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Use of crf receptor agonists for the treatment or prophylaxis of diseases, for example neurodegenerative diseases' [patent_app_type] => new [patent_app_number] => 10/240429 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16606 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186867.pdf [firstpage_image] =>[orig_patent_app_number] => 10240429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801585 [patent_doc_number] => 20030096750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Retinal pigmented epithelium derived neurotrophic factor' [patent_app_type] => new [patent_app_number] => 10/216373 [patent_app_country] => US [patent_app_date] => 2002-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33401 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096750.pdf [firstpage_image] =>[orig_patent_app_number] => 10216373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801585 [patent_doc_number] => 20030096750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Retinal pigmented epithelium derived neurotrophic factor' [patent_app_type] => new [patent_app_number] => 10/216373 [patent_app_country] => US [patent_app_date] => 2002-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33401 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096750.pdf [firstpage_image] =>[orig_patent_app_number] => 10216373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6725483 [patent_doc_number] => 20030207795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions' [patent_app_type] => new [patent_app_number] => 10/187498 [patent_app_country] => US [patent_app_date] => 2002-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 20596 [patent_no_of_claims] => 106 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207795.pdf [firstpage_image] =>[orig_patent_app_number] => 10187498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7025371 [patent_doc_number] => 20050019765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Methods for treating disorders of the nervous and reproductive systems' [patent_app_type] => utility [patent_app_number] => 10/479879 [patent_app_country] => US [patent_app_date] => 2002-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15164 [patent_no_of_claims] => 117 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20050019765.pdf [firstpage_image] =>[orig_patent_app_number] => 10479879 [rel_patent_id] =>[rel_patent_doc_number] =>)